. 2017 Sep;52(Pt 1).
doi: 10.1016/j.semcancer.2017.08.010.

Prognostic and predictive biomarkers in breast cancer: Past, present and future

Andrea Nicolini 1 Paola Ferrari 2 Michael J Duffy 3 
  • PMID: 28882552
  •     73 citations


Following a diagnosis of breast cancer, the most immediate challenges in patient management are the determination of prognosis and identification of the most appropriate adjuvant systemic therapy. Determining prognosis can best be addressed with a combination of traditional clinicopathological prognostic factors, biomarkers such as HER2/neu and specific multigene genes tests. Amongst the best validated prognostic multigene tests are uPA/PAI1, Oncotype DX and MammaPrint. Oncotype DX and MammaPrint, may be used for predicting outcome and aiding adjunct therapy decision making in patients with ER-positive, HER2-negative breast cancers that are either lymph node-negative or node positive (1-3 metastatic nodes), while uPA/PAI-1 may be similarly used in ER-positive, lymph node-negative patients. For selecting likely response to endocrine therapy, both estrogen receptors (ER) and progesterone receptors (PR) should be measured. On the other hand, for identifying likely response to anti-HER2 therapy, determination of HER2 gene amplification or overexpression is necessary. To identify new prognostic and predictive biomarkers for breast cancer, current research is focusing on tumor and circulating DNA (ctDNA) and RNA (e.g., micro RNAs) and circulating tumor cells. A promising ctDNA biomarker is the mutational status of ER (ESR1) for predicting the emergence of resistance to aromatase inhibitors. Challenges for future research include the identification of biomarkers for predicting response to radiotherapy and specific forms of chemotherapy.

Keywords: Biomarkers; Breast cancer; Micro RNAs; Prognostic; Therapy predictive.

The evolution of endometrial carcinoma classification through application of immunohistochemistry and molecular diagnostics: past, present and future.
Emily A Goebel, August Vidal, Xavier Matias-Guiu, C Blake Gilks.
Virchows Arch, 2017 Dec 14; 472(6). PMID: 29234950
Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications.
Niaz Mahmood, Catalin Mihalcioiu, Shafaat A Rabbani.
Front Oncol, 2018 Feb 28; 8. PMID: 29484286    Free PMC article.
Highly Cited. Review.
Single-Step Incubation Determination of miRNAs in Cancer Cells Using an Amperometric Biosensor Based on Competitive Hybridization onto Magnetic Beads.
Eva Vargas, Eloy Povedano, +6 authors, José M Pingarrón.
Sensors (Basel), 2018 Mar 16; 18(3). PMID: 29543716    Free PMC article.
Prognostic values of the mRNA expression of natural killer receptor ligands and their association with clinicopathological features in breast cancer patients.
Ali Abouelghar, Reem Hasnah, +2 authors, Manale Karam.
Oncotarget, 2018 Jun 23; 9(43). PMID: 29930758    Free PMC article.
The Role of Immune Escape and Immune Cell Infiltration in Breast Cancer.
André Steven, Barbara Seliger.
Breast Care (Basel), 2018 Jun 29; 13(1). PMID: 29950962    Free PMC article.
Increased High Molecular Weight FGF2 in Endocrine-Resistant Breast Cancer.
Ana Sahores, Virginia Figueroa, +14 authors, Caroline A Lamb.
Horm Cancer, 2018 Jun 30; 9(5). PMID: 29956066    Free PMC article.
Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort: a retrospective-prospective blinded study.
Anna Sofie Kappel Buhl, Troels Dreier Christensen, +17 authors, Peter Buhl Jensen.
Breast Cancer Res Treat, 2018 Aug 14; 172(2). PMID: 30099635    Free PMC article.
PARP9 is overexpressed in human breast cancer and promotes cancer cell migration.
Xinghong Tang, Hongying Zhang, +3 authors, Jing Jing.
Oncol Lett, 2018 Aug 22; 16(3). PMID: 30128030    Free PMC article.
Clinical Significance of Elevated S100A8 Expression in Breast Cancer Patients.
Dujuan Wang, Guohong Liu, +3 authors, Yunbao Pan.
Front Oncol, 2018 Nov 21; 8. PMID: 30456203    Free PMC article.
BCT score predicts chemotherapy benefit in Asian patients with hormone receptor-positive, HER2-negative, lymph node-negative breast cancer.
Mi Jeong Kwon, Sae Byul Lee, +8 authors, Young Kee Shin.
PLoS One, 2018 Nov 22; 13(11). PMID: 30462685    Free PMC article.
Comparative Proteome Analysis of Breast Cancer Tissues Highlights the Importance of Glycerol-3-phosphate Dehydrogenase 1 and Monoacylglycerol Lipase in Breast Cancer Metabolism.
Kubra Karaosmanoglu Yoneten, Murat Kasap, +3 authors, Nihat Zafer Utkan.
Cancer Genomics Proteomics, 2019 Aug 31; 16(5). PMID: 31467232    Free PMC article.
Panoptic View of Prognostic Models for Personalized Breast Cancer Management.
Geetanjali Saini, Karuna Mittal, +3 authors, Ritu Aneja.
Cancers (Basel), 2019 Sep 11; 11(9). PMID: 31500225    Free PMC article.
Surveillance of Tumour Development: The Relationship Between Tumour-Associated RNAs and Ribonucleases.
Nadezhda Mironova, Valentin Vlassov.
Front Pharmacol, 2019 Oct 02; 10. PMID: 31572192    Free PMC article.
Thermodynamics and kinetics guided probe design for uniformly sensitive and specific DNA hybridization without optimization.
Xin Chen, Na Liu, +8 authors, Xianjin Xiao.
Nat Commun, 2019 Oct 16; 10(1). PMID: 31611572    Free PMC article.
Region-specific glucocorticoid receptor promoter methylation has both positive and negative prognostic value in patients with estrogen receptor-positive breast cancer.
Hilary Snider, Brithica Villavarajan, +3 authors, Christopher R Mueller.
Clin Epigenetics, 2019 Nov 05; 11(1). PMID: 31675993    Free PMC article.
Baicalin Inhibits Cell Viability, Migration and Invasion in Breast Cancer by Regulating miR-338-3p and MORC4.
Xin Duan, Guangcheng Guo, +4 authors, Xinguang Qiu.
Onco Targets Ther, 2020 Jan 08; 12. PMID: 31908485    Free PMC article.
Competing Risk Analyses of Medullary Carcinoma of Breast in Comparison to Infiltrating Ductal Carcinoma.
Dongjun Dai, Rongkai Shi, +4 authors, Xian Wang.
Sci Rep, 2020 Jan 19; 10(1). PMID: 31953417    Free PMC article.
Metabolomics-Based Discovery of Molecular Signatures for Triple Negative Breast Cancer in Asian Female Population.
Lixian Li, Xiaodong Zheng, +4 authors, Tao Huan.
Sci Rep, 2020 Jan 17; 10(1). PMID: 31941951    Free PMC article.
CD56 expression in breast cancer induces sensitivity to natural killer-mediated cytotoxicity by enhancing the formation of cytotoxic immunological synapse.
Ghina Taouk, Ola Hussein, +4 authors, Manale Karam.
Sci Rep, 2019 Jun 21; 9(1). PMID: 31217484    Free PMC article.
STYK1 promotes tumor growth and metastasis by reducing SPINT2/HAI-2 expression in non-small cell lung cancer.
Zhiqiang Ma, Dong Liu, +9 authors, Xiaolong Yan.
Cell Death Dis, 2019 Jun 06; 10(6). PMID: 31164631    Free PMC article.
Hormone Receptor Expression in Multicentric/Multifocal versus Unifocal Breast Cancer: Especially the VDR Determines the Outcome Related to Focality.
Alaleh Zati Zehni, Sven-Niclas Jacob, +5 authors, Theresa Vilsmaier.
Int J Mol Sci, 2019 Nov 17; 20(22). PMID: 31731733    Free PMC article.
MRPS30-DT Knockdown Inhibits Breast Cancer Progression by Targeting Jab1/Cops5.
Balu Wu, Yunbao Pan, +4 authors, Yongchang Wei.
Front Oncol, 2019 Dec 04; 9. PMID: 31788446    Free PMC article.
Inhibition of PAI-1 limits chemotherapy resistance in lung cancer through suppressing myofibroblast characteristics of cancer-associated fibroblasts.
Takeshi Masuda, Taku Nakashima, +10 authors, Noboru Hattori.
J Cell Mol Med, 2019 Feb 09; 23(4). PMID: 30734495    Free PMC article.
A bioinformatics approach to identify novel long, non-coding RNAs in breast cancer cell lines from an existing RNA-sequencing dataset.
Oza Zaheed, Julia Samson, Kellie Dean.
Noncoding RNA Res, 2020 Mar 25; 5(2). PMID: 32206740    Free PMC article.
ERα, A Key Target for Cancer Therapy: A Review.
Yanfang Liu, Hong Ma, Jing Yao.
Onco Targets Ther, 2020 Mar 27; 13. PMID: 32210584    Free PMC article.
Sequential analysis of transcript expression patterns improves survival prediction in multiple cancers.
Jordan Mandel, Raghunandan Avula, Edward V Prochownik.
BMC Cancer, 2020 Apr 09; 20(1). PMID: 32264880    Free PMC article.
Recent advances in understanding breast cancer and emerging therapies with a focus on luminal and triple-negative breast cancer.
Georges El Hachem, Andrea Gombos, Ahmad Awada.
F1000Res, 2019 May 10; 8. PMID: 31069063    Free PMC article.
Artificial intelligence in oncology.
Hideyuki Shimizu, Keiichi I Nakayama.
Cancer Sci, 2020 Mar 07; 111(5). PMID: 32133724    Free PMC article.
Clinical Relevance of Liquid Biopsy in Melanoma and Merkel Cell Carcinoma.
Magali Boyer, Laure Cayrefourcq, +3 authors, Catherine Alix-Panabières.
Cancers (Basel), 2020 Apr 17; 12(4). PMID: 32295074    Free PMC article.
Differential miRNAs expression pattern of irradiated breast cancer cell lines is correlated with radiation sensitivity.
Nastaran Masoudi-Khoram, Parviz Abdolmaleki, +4 authors, Gustavo Baldassarre.
Sci Rep, 2020 Jun 05; 10(1). PMID: 32493932    Free PMC article.
RDGN-based predictive model for the prognosis of breast cancer.
Bing Dong, Ming Yi, +2 authors, Kongming Wu.
Exp Hematol Oncol, 2020 Jun 19; 9. PMID: 32550045    Free PMC article.
Prognostic and clinical significance of focal adhesion kinase expression in breast cancer: A systematic review and meta-analysis.
Weiqiang Qiao, Wenhui Wang, +3 authors, Miao Deng.
Transl Oncol, 2020 Jul 24; 13(11). PMID: 32702646    Free PMC article.
Mining the prognostic significance of the GINS2 gene in human breast cancer using bioinformatics analysis.
Shibo Yu, Lizhe Zhu, +5 authors, Yu Ren.
Oncol Lett, 2020 Jul 30; 20(2). PMID: 32724372    Free PMC article.
Clinical Perspective and Translational Oncology of Liquid Biopsy.
Diego Fernández-Lázaro, Juan Luis García Hernández, +3 authors, Juan Jesús Cruz-Hernández.
Diagnostics (Basel), 2020 Jul 08; 10(7). PMID: 32629823    Free PMC article.
Identification of key differentially expressed genes between ER-positive/HER2-negative breast cancer and ER-negative/HER2-negative breast cancer using integrated bioinformatics analysis.
Siyuan Gan, Haixia Dai, +7 authors, Yanqin Sun.
Gland Surg, 2020 Aug 11; 9(3). PMID: 32775256    Free PMC article.
Gene signature-based prediction of triple-negative breast cancer patient response to Neoadjuvant chemotherapy.
Yanding Zhao, Evelien Schaafsma, Chao Cheng.
Cancer Med, 2020 Jul 22; 9(17). PMID: 32692484    Free PMC article.
Oncologist Confidence in Genomic Testing and Implications for Using Multimarker Tumor Panel Tests in Practice.
Janet S de Moor, Stacy W Gray, +2 authors, Andrew N Freedman.
JCO Precis Oncol, 2020 Sep 15; 4. PMID: 32923869    Free PMC article.
In situ Metabolic Profiling of Ovarian Cancer Tumor Xenografts: A Digital Pathology Approach.
Ilaria Piga, Martina Verza, +6 authors, Stefano Indraccolo.
Front Oncol, 2020 Sep 26; 10. PMID: 32974128    Free PMC article.
Significant prognostic values of aquaporin mRNA expression in breast cancer.
Lizhe Zhu, Nan Ma, +5 authors, Yu Ren.
Cancer Manag Res, 2019 Mar 14; 11. PMID: 30863160    Free PMC article.
Tumor location of the central and nipple portion is associated with impaired survival for women with breast cancer.
Fei Ji, Wei-Kai Xiao, +10 authors, Kun Wang.
Cancer Manag Res, 2019 May 02; 11. PMID: 31040717    Free PMC article.
Dysregulation of DNA methylation patterns may identify patients with breast cancer resistant to endocrine therapy: A predictive classifier based on differentially methylated regions.
Fan Zhang, Yukun Cui.
Oncol Lett, 2019 Aug 20; 18(2). PMID: 31423189    Free PMC article.
High WDR34 mRNA expression as a potential prognostic biomarker in patients with breast cancer as determined by integrated bioinformatics analysis.
Dao-Jun Hu, Wen-Jie Shi, Miao Yu, Li Zhang.
Oncol Lett, 2019 Aug 28; 18(3). PMID: 31452794    Free PMC article.
Molecular Investigation on a Triple Negative Breast Cancer Xenograft Model Exposed to Proton Beams.
Francesco P Cammarata, Giusi I Forte, +13 authors, Giorgio Russo.
Int J Mol Sci, 2020 Sep 05; 21(17). PMID: 32882850    Free PMC article.
Artificial intelligence (AI) and big data in cancer and precision oncology.
Zodwa Dlamini, Flavia Zita Francies, Rodney Hull, Rahaba Marima.
Comput Struct Biotechnol J, 2020 Oct 01; 18. PMID: 32994889    Free PMC article.
Immunoglobulin superfamily member 10 is a novel prognostic biomarker for breast cancer.
Mengxue Wang, Meng Dai, +3 authors, Guosheng Ren.
PeerJ, 2020 Nov 06; 8. PMID: 33150070    Free PMC article.
HLA-J, a Non-Pseudogene as a New Prognostic Marker for Therapy Response and Survival in Breast Cancer.
Franziska M Würfel, Ralph M Wirtz, +8 authors, Claudio Zamagni.
Geburtshilfe Frauenheilkd, 2020 Nov 12; 80(11). PMID: 33173240    Free PMC article.
MYC Targets Scores Are Associated with Cancer Aggressiveness and Poor Survival in ER-Positive Primary and Metastatic Breast Cancer.
Amy Schulze, Masanori Oshi, Itaru Endo, Kazuaki Takabe.
Int J Mol Sci, 2020 Nov 05; 21(21). PMID: 33143224    Free PMC article.
Multidimensional Machine Learning Personalized Prognostic Model in an Early Invasive Breast Cancer Population-Based Cohort in China: Algorithm Validation Study.
Xiaorong Zhong, Ting Luo, +13 authors, Hong Zheng.
JMIR Med Inform, 2020 Nov 10; 8(11). PMID: 33164899    Free PMC article.
G-Protein-Coupled Receptor 5 (LGR5) Overexpression Activates β-Catenin Signaling in Breast Cancer Cells via Protein Kinase A.
Zhishui Chen, Chengjun Xue.
Med Sci Monit Basic Res, 2019 Jan 22; 25. PMID: 30662060    Free PMC article.
miR-135b-5p enhances doxorubicin-sensitivity of breast cancer cells through targeting anterior gradient 2.
Ying Zhang, Fan Xia, +4 authors, Yongping Wu.
J Exp Clin Cancer Res, 2019 Jan 23; 38(1). PMID: 30665445    Free PMC article.
ERβ modulates genistein's cisplatin-enhancing activities in breast cancer MDA-MB-231 cells via P53-independent pathway.
Ren Liu, Xiaolin Xu, +9 authors, Xiaojuan Hu.
Mol Cell Biochem, 2019 Feb 10; 456(1-2). PMID: 30737644
The effect of chemotherapy on subjective cognitive function in younger early-stage breast cancer survivors treated with chemotherapy compared to older patients.
M L Gregorowitsch, A Ghedri, +9 authors, UMBRELLA study group.
Breast Cancer Res Treat, 2019 Feb 13; 175(2). PMID: 30746636    Free PMC article.
The interplay of circulating tumor DNA and chromatin modification, therapeutic resistance, and metastasis.
Lei Zhang, Yiyi Liang, +6 authors, Fenglei Yu.
Mol Cancer, 2019 Mar 10; 18(1). PMID: 30849971    Free PMC article.
The Advent of Salivary Breast Cancer Biomarker Detection Using Affinity Sensors.
Imad Abrao Nemeir, Joseph Saab, +3 authors, Nadia Zine.
Sensors (Basel), 2019 May 28; 19(10). PMID: 31126047    Free PMC article.
Impact of uPA/PAI-1 and disseminated cytokeratin-positive cells in breast cancer.
Bruno Märkl, Martin Kazik, +7 authors, Daniel Oruzio.
BMC Cancer, 2019 Jul 17; 19(1). PMID: 31307406    Free PMC article.
A 23 gene-based molecular prognostic score precisely predicts overall survival of breast cancer patients.
Hideyuki Shimizu, Keiichi I Nakayama.
EBioMedicine, 2019 Jul 31; 46. PMID: 31358476    Free PMC article.
FABP7 is a potential biomarker to predict response to neoadjuvant chemotherapy for breast cancer.
Qin Xie, Ying-Sheng Xiao, +7 authors, De Zeng.
Cancer Cell Int, 2020 Dec 10; 20(1). PMID: 33292226    Free PMC article.
Application of Biomarkers for the Prediction and Diagnosis of Bone Metastasis in Breast Cancer.
Feiqi Liu, Jianji Ke, Yanqiu Song.
J Breast Cancer, 2021 Jan 08; 23(6). PMID: 33408885    Free PMC article.
LncRNA TINCR favors tumorigenesis via STAT3-TINCR-EGFR-feedback loop by recruiting DNMT1 and acting as a competing endogenous RNA in human breast cancer.
Qin Wang, Jiena Liu, +9 authors, Da Pang.
Cell Death Dis, 2021 Jan 16; 12(1). PMID: 33446634    Free PMC article.
Machine-Learning Provides Patient-Specific Prediction of Metastatic Risk Based on Innovative, Mechanobiology Assay.
Rakefet Rozen, Daphne Weihs.
Ann Biomed Eng, 2021 Jan 24;. PMID: 33483841
Is It Possible to Personalize the Diagnosis and Treatment of Breast Cancer during Pregnancy?
Petra Tesarova, David Pavlista, Antonin Parizek.
J Pers Med, 2021 Jan 01; 11(1). PMID: 33379383    Free PMC article.
miRNA-195 expression in the tumor tissues of female Brazilian breast cancer patients with operable disease.
Alexandre Cesar Vieira de Sales, Isaura Isabelle Fonseca Gomes da Silva, +5 authors, Fabrício Oliveira Souto.
Clinics (Sao Paulo), 2021 Jan 28; 76. PMID: 33503182    Free PMC article.
Bringing Greater Accuracy to Europe's Healthcare Systems: The Unexploited Potential of Biomarker Testing in Oncology.
Denis Horgan, Gennaro Ciliberto, +46 authors, Giuseppe Curigliano.
Biomed Hub, 2021 Feb 11; 5(3). PMID: 33564664    Free PMC article.
Current Achievements and Applications of Transcriptomics in Personalized Cancer Medicine.
Stanislaw Supplitt, Pawel Karpinski, Maria Sasiadek, Izabela Laczmanska.
Int J Mol Sci, 2021 Feb 13; 22(3). PMID: 33572595    Free PMC article.
A New Horizon of Liquid Biopsy in Thymic Epithelial Tumors: The Potential Utility of Circulating Cell-Free DNA.
Margaret Ottaviano, Mario Giuliano, +16 authors, Giovannella Palmieri.
Front Oncol, 2021 Feb 27; 10. PMID: 33634024    Free PMC article.
Pre-treatment neutrophil-lymphocyte and platelet-lymphocyte ratios as additional markers for breast cancer progression: A retrospective cohort study.
Sumadi Lukman Anwar, Roby Cahyono, +3 authors, Teguh Aryandono.
Ann Med Surg (Lond), 2021 Mar 05; 63. PMID: 33659054    Free PMC article.
Dynamic contrast enhanced-MRI and diffusion-weighted image as predictors of lymphovascular invasion in node-negative invasive breast cancer.
Bo Bae Choi.
World J Surg Oncol, 2021 Mar 17; 19(1). PMID: 33722246    Free PMC article.
Identification of Five Immune-Related lncRNAs Predicting Survival and Tumor Microenvironment Characteristics in Breast Cancer.
Ran Xiao, Meng Yang, +2 authors, Duolu Li.
Comput Math Methods Med, 2021 Mar 18; 2021. PMID: 33727952    Free PMC article.
Expression and prognosis analysis of GINS subunits in human breast cancer.
Hongtao Li, Yanzhen Cao, +2 authors, Binlin Ma.
Medicine (Baltimore), 2021 Mar 18; 100(11). PMID: 33725952    Free PMC article.
Background parenchymal enhancement and breast cancer: a review of the emerging evidences about its potential use as imaging biomarker.
Rossella Rella, Andrea Contegiacomo, +3 authors, Riccardo Manfredi.
Br J Radiol, 2020 Oct 10; 94(1119). PMID: 33035073    Free PMC article.
Systematic Review.
Hyperglycemia-Induced miR-467 Drives Tumor Inflammation and Growth in Breast Cancer.
Jasmine Gajeton, Irene Krukovets, +3 authors, Olga Stenina-Adognravi.
Cancers (Basel), 2021 Apr 04; 13(6). PMID: 33809756    Free PMC article.
Molecular interactions of miR-338 during tumor progression and metastasis.
Meysam Moghbeli.
Cell Mol Biol Lett, 2021 Apr 09; 26(1). PMID: 33827418    Free PMC article.
Predicting clinical outcomes using cancer progression associated signatures.
Jared Mamrot, Nathan E Hall, Robyn A Lindley.
Oncotarget, 2021 Apr 24; 12(8). PMID: 33889305    Free PMC article.